| Tag | Content |
|---|
EnhancerAtlas ID | HS002-01056 |
Organism | Homo sapiens |
Tissue/cell | A375 |
Coordinate | chr1:206943240-206944250 |
Target genes | |
SNPs | | Number: 2 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Myod1 | MA0499.1 | chr1:206944212-206944225 | GGGGGCAGCTGCA | - | 6.08 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_18640 | chr1:206941837-206946910 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19631 | chr1:206941922-206945291 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_61266 | chr1:206939355-206991151 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TGTGGAAGAA AAGAGAAAGT GTTGGTGATC CTGGCTTCCA GCTCCATGTC CATCACACTT 60
AGGGGACAAG CTGGTGGCAT CATGAGGAGG CCAGATTTAT CCAAATGCCT TGCCTCACAG 120
CTCCCAGAGA GAACTGAGCC CTGCTTCCAT GGCCCTGGGA GTTAAATGTA TTTCTCCAGG 180
ACTCACTCCA AGATGTTTGC AAGGCTTGGA TGACAACCCA GGTCTTGGGA TTCCTTCCTC 240
CCCCAGAACT CTACAGTATC TCCTGCAGTG CTGAGCGAGG CATTCTTCAG CCTGTCCTTT 300
TCTGCCTCTC TCTCCTGTTC CTCCCCGTCA GTCACAGCCA CCGAGGAACA CTTCTAAGCA 360
TCTGAGGAGG GAAGCTACTG GGACCAAACC CTTCACATAG CCTTGTCCTA CAAATAGACA 420
CCAACTGATT TTCCAATATT GGTGACAGAA CAGGGGAAAC CATTAGTAGT GAGGGCATCA 480
TTTCAGTTGG AGAAATAAAT TACCTGGAGG AATTACTCAT AGACACTAGC CTGGGGATGA 540
ATAGCCCCCT TGTCCCTTCT AAAATGCCAG GGGAAATCCT GTCAGTCAAT TGGGCCCTTC 600
TTAGAGCTTT GCTTTCAAAA CATTGAGATT AAAAGAGGTG AATGATGTTT CCTCTGCTTG 660
GGAACCTTAG CTCCCCGCCC AGGGTCTAGT TACAAAGAGG CAGTGGAGGC CTGACTGAAG 720
CTCTGGGCTC CTTTTATGAA GAGAGAGGGG AGTAGTTAAT AACCCACAAA TGACTCACAA 780
ATAACAGGAA AGCTGTTTGC AAATTTCACA TGTAAATGCC TAGCAGCCAC CCCCAACGCC 840
TGCTCAAAGA GAAATGAGCA AGAGATCTGA CTCCAGGAGT CTTTCCTCAT TTACAGCTAG 900
CTCTGCCAGT CTGTGTCTTT GCTGTGTCTG TGGATGTGAG TGTCCCTGCT GGTCTGTAGG 960
AGATGGTATT TTGGGGGCAG CTGCAAGGGA AAAAACTGAT CTGCTACTTA 1010
|
